Philippines Business News API

{
    "totalArticles": 306650,
    "articles": [
        {
            "id": "36efd97fbc165f66358fbc1c7535b945",
            "title": "Hanwha Power Signs Strategic Memorandum of Understanding with Canadian Energy Company Pembina Pipeline for Lower-Carbon Power Generation Business",
            "description": "**media[1066008]**Strategic cooperation is pursued as part of the ITB program linked to the Hanwha Ocean Canada Submarine Program(CPSP)Power generation from waste heat discarded by pipeline boosters, establishing a carbon-reduction solution for North American energy infrastructureExpanding the foundation for the commercialization of waste heat recovery power generation targeting North American pipeline boostersCALGARY, AB and SEOUL, South Korea, May 21, 2026 /PRNewswire/ -- Hanwha Power (CEO Rafi Balta) announced on the 20th local time that it had signed a non-binding memorandum of understanding (MOU) with Pembina Pipeline Corporation (Pembina), a leading Canadian energy transportation and midstream service provider that has served North America's energy industry for more than 70 years, to collaborate on a low-carbon power generation project.**media[1066009]**",
            "content": "Strategic cooperation is pursued as part of the ITB program linked to the Hanwha Ocean Canada Submarine Program(CPSP)\nPower generation from waste heat discarded by pipeline boosters, establishing a carbon-reduction solution for North American energy ... [3865 chars]",
            "url": "https://www.manilatimes.net/2026/05/21/tmt-newswire/pr-newswire/hanwha-power-signs-strategic-memorandum-of-understanding-with-canadian-energy-company-pembina-pipeline-for-lower-carbon-power-generation-business/2348744",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/05/21/1066006.jpg",
            "publishedAt": "2026-05-21T00:22:40Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        },
        {
            "id": "21a3d17908e253c72ba100a28b031798",
            "title": "Sysco to Webcast Presentation at the Deutsche Bank Access Global Consumer Conference 2026",
            "description": "HOUSTON, May 20, 2026 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) today announced that the Company will webcast its presentation from the 2026 Deutsche Bank Access Global Consumer Conference in Paris, France on Tuesday, June 2, at 8:45 a.m. CT or 3:45 p.m. CEST.The live webcast for the event can be accessed at",
            "content": "HOUSTON, May 20, 2026 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) today announced that the Company will webcast its presentation from the 2026 Deutsche Bank Access Global Consumer Conference in Paris, France on Tuesday, June 2, at 8:45 a.m. CT o... [1831 chars]",
            "url": "https://investors.sysco.com/annual-reports-and-sec-filings/news-releases/2026/05-20-2026-213508981",
            "image": "https://investors.sysco.com/~/media/Images/S/Sysco-IR/logo/sysco-share-logo-v2.jpg",
            "publishedAt": "2026-05-20T20:59:11Z",
            "lang": "en",
            "source": {
                "id": "6f92fea9ffa605fc9851a4f4c7d460e4",
                "name": "Sysco",
                "url": "https://investors.sysco.com"
            }
        },
        {
            "id": "0c153513de98a725a065c84df7907595",
            "title": "Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering",
            "description": "Jupiter, FL, May 20, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ('Jupiter' or the 'Company'), a clinical-stage biopharmaceutical company focused on central nervous system disorders and neuroinflammation, today announced it has entered into a securities purchase agreement for the purchase and sale of 7,142,858 shares of common stock in a registered direct offering.",
            "content": "Jupiter, FL, May 20, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (\"Jupiter\" or the \"Company\"), a clinical-stage biopharmaceutical company focused on central nervous system disorders and neuroinflammation, today announced it ha... [3755 chars]",
            "url": "https://www.manilatimes.net/2026/05/21/tmt-newswire/globenewswire/jupiter-neurosciences-announces-pricing-of-20-million-registered-direct-offering/2348601",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/05/21/1065799.tiff",
            "publishedAt": "2026-05-20T18:49:06Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        }
    ]
}